このエントリーをはてなブックマークに追加
ID 67657
JaLCDOI
フルテキストURL
78_5_371.pdf 3.14 MB
著者
Gotoh, Kazuyoshi Department of Bacteriology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Miyoshi, Makoto Department of Medical Laboratory Science, Graduate School of Health Sciences, Okayama University
I Putu Bayu Mayura Department of Clinical Microbiology, Faculty of Medicine, Udayana University
Tsuji, Shuma Department of Medical Laboratory Science, Graduate School of Health Sciences, Okayama University
Iio, Koji Microbiology Division, Clinical Laboratory, Okayama University Hospital
Fukushima, Shinnosuke Department of Bacteriology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Matsushita, Osamu Department of Bacteriology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID researchmap
Hagiya, Hideharu Department of Infectious Diseases, Okayama University Hospital ORCID Kaken ID researchmap
抄録
Spread of carbapenemase-producing Enterobacterales (CPE) is an ongoing public health issue worldwide, including in Japan. In this study, we investigated the phenotypic and genetic characteristics of CPE isolates at Okayama University Hospital over the 5 years (2013-2018) prior to the outbreak of the 2019 coronavirus pandemic. Of 24 carbapenem-resistant Enterobacterales isolated during the study period, we identified 8 CPE isolates harboring blaIMP-1 (5 isolates) and blaIMP-6 genes (3 isolates). Bacterial species and carbapenem susceptibility patterns exhibited diversity. Minimum inhibitory concentrations (MICs) of meropenem were generally higher than those of imipenem and biapenem. Results of pulsed-field gel electrophoresis demonstrated that neither clonal nor plasmid-mediated outbreaks of blaIMP-harboring CPE isolates have developed at our hospital. One Klebsiella oxytoca isolate showed a high MIC (128 μg/mL) of meropenem, which could be explained by the high plasmid copy number. Subsequent analysis of this isolate may elucidate the intricacies of carbapenem resistance profiles among CPE isolates. Collectively, our findings underscore the necessity for ongoing genetic surveillance of CPE, complemented by tailored approaches for infection prevention and control.
キーワード
antimicrobial resistance
carbapenemase-producing enterobacterales
carbapenemase-resistant enterobacterales
Silent pandemic
whole genome sequence
Amo Type
Original Article
出版物タイトル
Acta Medica Okayama
発行日
2024-10
78巻
5号
出版者
Okayama University Medical School
開始ページ
371
終了ページ
376
ISSN
0386-300X
NCID
AA00508441
資料タイプ
学術雑誌論文
言語
英語
著作権者
Copyright Ⓒ 2024 by Okayama University Medical School
論文のバージョン
publisher
査読
有り
PubMed ID
Web of Science KeyUT